Court overturns record cartel fines in Lithuania

We represented Gintarinė vaistinė and Limedika in a major antitrust case—the largest in Lithuania’s history. These pharmaceutical companies were fined over EUR 25 million by the Lithuanian Competition Council (LCC) for allegedly coordinating with competitors while lobbying. The LCC claimed they submitted data to the Ministry of Health that influenced the Ministry’s decision to approve […]

OC VISION completes debut bond issue

OC VISION, the largest vision care company in the Baltics, has successfully raised EUR 10 million through its first public bond offering with a fixed annual coupon rate of 6%. Total demand for the secured bonds reached EUR 13.1 million, oversubscribed by more than 130%. About the bond offering The offering attracted interest from both […]

From compulsory licensing to AI in healthcare: what’s changing in the Baltics and beyond?

In this newsletter, we discuss legal news which broadly impacts the life sciences and healthcare sector, as well as updates specifically relevant to research and development. This time we are covering: At the EU level, the Council is now ready to begin negotiations with the European Parliament about the “pharma package”, and a regulation is […]

63rd International Young Lawyers’ Congress in Washington D.C.

Livonia Partners invests in Estonian healthcare company

We advised Livonia Partners, one of the leading private equity funds in the Baltics, on acquiring a majority stake in Medicum, one of Estonia’s largest healthcare companies. Founded in 1986, Medicum’s group of 450 employees provides general and specialised medical care across five locations in Tallinn, Harju County and Tartu. The involvement of Livonia Partners […]